Trainee Patent Attorney

Anathe Patschull

Hilversum

Anathe joined Kilburn & Strode in January 2022 and has several years’ experience in drafting and prosecuting patent applications in the fields of polymers, biotechnology, agrotechnology, feed and food technology. 
 
Before joining Kilburn & Strode, she was a UK IPO patent examiner in the fields of food technology, feed technology, medical devices, biotechnology and pharmaceuticals; as well as working as a trainee patent attorney.
 
Anathe completed a PhD in Biophysics, Bioinformatics and Biochemistry at the ISMB, publishing 5 papers on computational drug discovery methods and on the first viral protein-miRNA X-ray structure. During her BSc in Biochemistry, she conducted research into Alzheimer using antibody labelling and transmission electron microscopy (TEM) as well as research into Ag+ complexes as antimicrobials.
 
Her Master in Management of Intellectual Property at Queen Mary dissertation focused on the interplay between health economics, patent law and marketing authorisation of orphan drugs.
 

Dutch

 Anathe trad in januari 2022 in dienst bij Kilburn & Strode en heeft meerdere jaren ervaring in het opstellen van octrooien en opvolging van de octrooiverleningsprocedure op het gebied van polymeren, biotechnologie, agrotechnologie, voeder- en voedseltechnologie.
 
Voordat ze bij Kilburn & Strode kwam, was ze een patent examinator bij de UK IPO op het gebied van voedseltechnologie, voedertechnologie, medische hulpmiddelen, biotechnologie en farmaceutica; en werkzaam als octrooigemachtigde in opleiding.
 
Anathe voltooide een doctoraat in biofysica, bio-informatica en biochemie aan de ISMB en publiceerde 5 papers over computationele methoden voor het ontdekken van geneesmiddelen en over de eerste virale eiwit-miRNA-X-ray structuur.
 
Tijdens haar BSc in Biochemie deed ze onderzoek naar Alzheimer met behulp van antilichaamlabeling en transmissie-elektronenmicroscopie (TEM), evenals onderzoek naar Ag+-complexen als antimicrobiële stoffen.
 
Haar Master proefschrift in Management of Intellectual Property aan het Queen Mary University was gericht op de wisselwerking tussen gezondheidseconomie, octrooirecht en de vergunning voor het in de handel brengen van weesgeneesmiddelen.

MSc in Management of Intellectual Property (Distinction) at Queen Mary University

PGCert in Intellectual Property Law at Queen Mary University

PhD in Biophysics, Bioinformatics & Biochemistry at Institute of Structural & Molecular Biology (ISMB – UCL, Birkbeck & NIMR)

BSc in Biochemistry (1st Class) at University of Sussex

Patschull, AOM, et al. (2017) “KSHV SOX mediated host shutoff: The molecular mechanism underlying mRNA transcript processing revealed.” Nucleic Acids Research.

Patschull, AOM, et al. (2012) “
In Silico Assessment of Potential Druggable Pockets on the Surface of a1-Antitrypsin.” Plos One.

Nyon, MP, Segu, L, Cabrita, LD, Kirkpatrick, J, Roussel, BD, Patschull, AOM, et al. (2012) “
Structural Dynamics Associated with Intermediate Formation in an Archetypal Conformational Disease.” Structure.

Patschull, AOM, et al. (2011) “
Therapeutic Target-Site Variability in a1-Antitrypsin Characterized at High Resolution.” Acta Crystallographica Section F-Structural Biology and Crystallization Communications.

Chang, YP, Mahadeva, R, Patschull, AOM, et al. (2011) “
Targeting Serpins In High-Throughput and Structure-Based Drug Design.” Methods In Enzymology: Serpin Structure.

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept